Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOSERINE Cause Intentional product use issue? 65 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Intentional product use issue have been filed in association with CYCLOSERINE (Cycloserine). This represents 4.5% of all adverse event reports for CYCLOSERINE.

65
Reports of Intentional product use issue with CYCLOSERINE
4.5%
of all CYCLOSERINE reports
22
Deaths
30
Hospitalizations

How Dangerous Is Intentional product use issue From CYCLOSERINE?

Of the 65 reports, 22 (33.8%) resulted in death, 30 (46.2%) required hospitalization, and 6 (9.2%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOSERINE. However, 65 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOSERINE Cause?

Electrocardiogram qt prolonged (233) Off label use (177) Vomiting (147) Anaemia (143) Neuropathy peripheral (123) Nausea (116) Hepatotoxicity (91) Tuberculosis (78) Drug resistance (75) Dyspnoea (73)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which CYCLOSERINE Alternatives Have Lower Intentional product use issue Risk?

CYCLOSERINE vs CYCLOSPORINE CYCLOSERINE vs CYCLOSPORINE A CYCLOSERINE vs CYMBALTA CYCLOSERINE vs CYNODON DACTYLON POLLEN CYCLOSERINE vs CYPROHEPTADINE

Related Pages

CYCLOSERINE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue CYCLOSERINE Demographics